Pola-ZR2P in Previously Untreated DLBCL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pola-ZR2P in Previously Untreated DLBCL — Stella

Home/Diffuse Large B-cell Lymphoma/

View on ClinicalTrials.gov

Recruiting

Back to Diffuse Large B-cell Lymphoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Navy General Hospital, Beijing, Beijing Municipality

Key details

Phase

Safety & dosing

Sponsor

Navy General Hospital, Beijing

Enrollment target

~80 participants

Started

September 2024

Primary completion

December 2029

Age range

14 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.